HDAC inhibitors, having many effects on various types of cellular functions, can modulate the transcription of cancer-related gene expression by histone acetylation [25], [26] and thus be considered as candidate drugs in cancer therapy [27], [28]. Here, HDAC9 is linked to cancer.